CINECA IRIS Institutional Research Information System

Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)

Horwitz, SM;Scarisbrick, JJ;Dummer, R;Duvic, M;Kim, YH;Walewski, J;Whittaker, S;Quaglino, P;Zinzani, PL;Wolter, P;Eradat, H;Sanches, JA;Ortiz-Romero, PL;Akilov, OE;Trotman, J;Taylor, K;Dalle, S;Weichenthal, M;Fisher, DC;Stadler, R;Feldman, TA;Kuzel, TM;Gru, AA;Wang, YH;Palanca-Wessels, MC;Lin, HM;Liu, Y;Little, M;Prince, HM

2017-01-01